Mazdutide

Description

mazdutide is an innovative peptide based on oxyntomodulin, aimed at simultaneously affecting the centers of saturation and lipid metabolism. its molecule is stabilized by the addition of a fatty acid side chain, which provides a prolonged effect: one injection per week is enough. Activation of glp-1 receptors reduces appetite and improves glucose control, while stimulation of receptors accelerates lipolysis and thermogenesis. Clinical data demonstrate significant weight loss even in patients with severe obesity and resistance to other treatments.

Mazdutide in ampoule format is a highly concentrated dual-receptor metabolic modulator designed for rapid enhancement of lipolysis, glycemic control, and energy expenditure. This format is used when a fast metabolic activation or intensified early-phase response is required.

Mazdutide activates both GLP-1, improving substrate utilization, reducing appetite, and boosting thermogenesis. The simultaneous activation of these pathways creates a balanced metabolic profile that supports fat reduction and improved body composition.

Mazdutide is suitable for individuals with high treatment resistance, athletes in fat-loss phases, and patients requiring a rapid, pronounced metabolic effect. The format accelerates adaptation, enhances energy efficiency, and helps achieve visible results faster.